Page last updated: 2024-10-31

metronidazole and Birth Weight

metronidazole has been researched along with Birth Weight in 10 studies

Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.

Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
"To determine whether metronidazole reduces early preterm labour in asymptomatic women with positive vaginal fetal fibronectin (fFN) in the second trimester of pregnancy."5.12A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. ( Briley, A; Crawshaw, S; Hawken, J; Jones, G; Poston, L; Seed, P; Shennan, A, 2006)
"To ascertain whether adjuvant ampicillin and metronidazole given to women in preterm labour with intact membranes would prolong pregnancy and decrease the perinatal mortality and morbidity."5.07Ampicillin and metronidazole treatment in preterm labour: a multicentre, randomised controlled trial. ( de Jong, P; de Souza, J; Kirsten, G; Moller, G; Norman, K; Pattinson, RC, 1994)
"Sexually transmitted diseases were reduced: Trichomonas vaginalis (rate ratio, 0."2.70Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. ( Abramowsky, C; Gray, RH; Kigozi, G; Meehan, M; Moulton, LH; O'Brien, KL; Quinn, TC; Robb, M; Serwadda, D; Sewankambo, NK; Wabwire-Mangen, F; Wawer, MJ, 2001)
" Driven by these differences and recent legislation mandating the study of drugs in children and neonates, an increasing number of pharmacokinetic studies of antibiotics are being performed in neonates."1.46Dosing antibiotics in neonates: review of the pharmacokinetic data. ( Cohen-Wolkowiez, M; Greenberg, RG; Rivera-Chaparro, ND, 2017)
"Metronidazole population PK was best described by a 1-compartment model."1.38Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants. ( Benjamin, DK; Cohen-Wolkowiez, M; James, LP; Kashuba, AD; Newman, N; Ouellet, D; Ross, A; Smith, PB; Sullivan, JE; Walsh, MC; White, NR; Zadell, A, 2012)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's5 (50.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rivera-Chaparro, ND1
Cohen-Wolkowiez, M2
Greenberg, RG1
Briery, CM1
Chauhan, SP1
Magann, EF1
Cushman, JL1
Morrison, JC1
Ouellet, D1
Smith, PB1
James, LP1
Ross, A1
Sullivan, JE1
Walsh, MC1
Zadell, A1
Newman, N1
White, NR1
Kashuba, AD1
Benjamin, DK1
Kazy, Z2
Puhó, E2
Czeizel, AE2
Sen, A1
Mahalanabis, D1
Mukhopadhyay, S1
Chakrabarty, K1
Singh, AK1
Bisai, S1
Chakrabarty, M1
Halder, D1
Islam, MA1
Shennan, A1
Crawshaw, S1
Briley, A1
Hawken, J1
Seed, P1
Jones, G1
Poston, L1
Ross, SM1
van Middelkoop, A1
Norman, K1
Pattinson, RC1
de Souza, J1
de Jong, P1
Moller, G1
Kirsten, G1
Gray, RH1
Wabwire-Mangen, F1
Kigozi, G1
Sewankambo, NK1
Serwadda, D1
Moulton, LH1
Quinn, TC1
O'Brien, KL1
Meehan, M1
Abramowsky, C1
Robb, M1
Wawer, MJ1

Trials

5 trials available for metronidazole and Birth Weight

ArticleYear
Routine use of antimicrobials by pregnant Indian women does not improve birth outcome: a randomized controlled trial.
    Journal of health, population, and nutrition, 2005, Volume: 23, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Birth Weight; Cephalexin; Female; Genital Diseases, Female; Gestationa

2005
A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    BJOG : an international journal of obstetrics and gynaecology, 2006, Volume: 113, Issue:1

    Topics: Administration, Oral; Adult; Anti-Infective Agents; Biomarkers; Birth Weight; Cervix Uteri; Double-B

2006
Trichomonas infection in pregnancy--does it affect perinatal outcome?
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1983, Apr-09, Volume: 63, Issue:15

    Topics: Antitrichomonal Agents; Birth Weight; Female; Humans; Infant, Newborn; Metronidazole; Pregnancy; Pre

1983
Ampicillin and metronidazole treatment in preterm labour: a multicentre, randomised controlled trial.
    British journal of obstetrics and gynaecology, 1994, Volume: 101, Issue:5

    Topics: Adult; Ampicillin; Birth Weight; Drug Therapy, Combination; Female; Gestational Age; Humans; Metroni

1994
Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda.
    American journal of obstetrics and gynecology, 2001, Volume: 185, Issue:5

    Topics: Azithromycin; Birth Weight; Cefixime; Drug Therapy, Combination; Endophthalmitis; Female; Folic Acid

2001

Other Studies

5 other studies available for metronidazole and Birth Weight

ArticleYear
Dosing antibiotics in neonates: review of the pharmacokinetic data.
    Future microbiology, 2017, Volume: 12

    Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Birth Weight; Body Size; Cephalosporins

2017
Treatment of bacterial vaginosis does not reduce preterm birth among high-risk asymptomatic women in fetal fibronectin positive patients.
    Journal of the Mississippi State Medical Association, 2011, Volume: 52, Issue:3

    Topics: Adult; Anti-Infective Agents; Apgar Score; Birth Weight; Chi-Square Distribution; Enzyme-Linked Immu

2011
Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:4

    Topics: Anti-Infective Agents; Bayes Theorem; Birth Weight; Chromatography, High Pressure Liquid; Creatinine

2012
Gestational age and prevalence of preterm birth after vaginal metronidazole treatment during pregnancy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2004, Volume: 87, Issue:2

    Topics: Administration, Intravaginal; Anti-Infective Agents; Birth Weight; Case-Control Studies; Female; Ges

2004
Effect of vaginal metronidazole + miconazole treatment during pregnancy for gestational age and birth weight in a population-based study.
    Archives of gynecology and obstetrics, 2005, Volume: 272, Issue:4

    Topics: Administration, Intravaginal; Adult; Antifungal Agents; Birth Weight; Case-Control Studies; Female;

2005